Literature DB >> 16800416

Invasive aspergillosis with central nervous system dissemination in a presumably immunocompetent, non-neutropenic patient: case report and review.

Roberto J Garcia1, Pedro Troya, Charles Edwards.   

Abstract

We present a case of a 45-year-old gentlemen with invasive Aspergillosis who has no apparent immune deficiencies. Follow up imaging shows improvement after the initiation of therapy. The case is accompanied by a brief discussion over invasive aspergillosis.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16800416     DOI： 10.1097/01.smj.0000217123.43673.90

Source DB:  PubMed          Journal:  South Med J        ISSN： 0038-4348            Impact factor:   0.954


  5 in total

1.  The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.

Authors:  S Schwartz; A Reisman; P F Troke
Journal:  Infection       Date:  2011-04-22       Impact factor: 3.553

2.  Aspergillosis of the central nervous system in a previously healthy patient that simulated Creutzfeldt-Jakob disease.

Authors:  Adrián Santana-Ramírez; Sergio V Esparza-Gutiérrez; Pedro Avila-Rodríguez; J Eugenio Jiménez-Gómez; Ezequiel Vélez-Gómez; David Bañuelos-Gallo
Journal:  Surg Neurol Int       Date:  2016-12-05

3.  Pseudomembranous aspergillar tracheobronchitis in a non-neutropenic critically ill patient in the intensive care unit.

Authors:  Sameen Khalid; Fnu Asad-Ur -Rahman; Aamer Abbass; Sigfredo Aldarondo; Khalid Abusaada
Journal:  J Community Hosp Intern Med Perspect       Date:  2017-03-31

Review 4.  A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins.

Authors:  Janette Hope
Journal:  ScientificWorldJournal       Date:  2013-04-18

5.  Central Nervous System Aspergilloma in an Immunocompetent Patient: A Case Report.

Authors:  Hasanreza Mohammadi; Sohrab Sadeghi; Shokrollah Zandi
Journal:  Iran J Public Health       Date:  2015-06       Impact factor: 1.429
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.